Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session

Published 13/12/2022, 17:14
© Reuters.  Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session
IXIC
-
OPGN
-
TGTB34
-

Benzinga - Gainers

  • OpGen, Inc. (NASDAQ: OPGN) shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
  • Netcapital Inc. (NASDAQ: NCPL) shares jumped 100% to $2.77 following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
  • Onion Global Limited (NYSE: OG) gained 65% to $0.33.
  • Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares jumped 46.7% to $0.2171.
  • Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) rose 33.3% to $0.6119 after surging over 55% on Monday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company
  • BeyondSpring Inc. (NASDAQ: BYSI) jumped 31% to $0.9995 after the company presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
  • Fluence Energy, Inc. (NASDAQ: FLNC) shares gained 28% to $22.05 after the company reported better-than-expected Q4 sales.
  • Shineco, Inc. (NASDAQ: SISI) jumped 27% to $1.6518 after the company announced its subsidary was granted a USPTO patent and FDA marketing approval for its in-situ fecal specimen sampling device.
  • Gritstone bio, Inc. (NASDAQ: GRTS) gained 27% to $3.2807. Gritstone bio was granted two new US patents for self-amplifying mRNA.
  • Prenetics Global Limited (NASDAQ: PRE) rose 27% to $2.35. Prenetics recently announced a $20 million buyback.
  • SenesTech, Inc. (NASDAQ: SNES) gained 26% to $3.13.
  • Magenta Therapeutics, Inc. (NASDAQ: MGTA) gained 25.2% to $1.44 after the company highlighted updated data from the ongoing MGTA-117 Phase 1/2 dose-escalation trial at the American Society of Hematology 2022 Annual (ASH) Meeting.
  • Grom Social Enterprises, Inc. (NASDAQ: GROM) rose 24.8% to $1.65.
  • ClearSign Technologies Corporation (NASDAQ: CLIR) jumped 24.8% to $0.69.
  • Moderna (NASDAQ:MRNA), Inc. (NASDAQ: MRNA) surged 22.8% to $202.86 after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary efficacy endpoint in the Phase 2b KEYNOTE-942 trial.
  • Schrödinger, Inc. (NASDAQ: SDGR) rose 22.6% to $20.88.
  • Dada Nexus Limited (NASDAQ: DADA) gained 21.7% to $8.02. Shares of Chinese companies traded higher following the recent easing of Covid restrictions in China, which has helped increase travel activity.
  • MamaMancini's Holdings, Inc. (NASDAQ: MMMB) rose 21.4% to $1.5308 following better-than-expected Q3 results.
  • Ventyx Biosciences, Inc. (NASDAQ: VTYX) rose 21.4% to $34.70 after gaining over 5% on Monday.
  • Rallybio Corporation (NASDAQ: RLYB) shares climbed 19.8% to $10.43. JP Morgan, last week, initiated coverage on Rallybio with an Overweight rating and announced a price target of $21.
  • ACM Research, Inc. (NASDAQ: ACMR) gained 19.6% to $10.43.
  • Wave Life Sciences Ltd. (NASDAQ: WVE) gained 19.4% to $4.3115. Wave Life Sciences and GSK plc have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave's preclinical RNA editing program targeting alpha-1 antitrypsin deficiency, WVE-006.
  • Kaspien Holdings Inc. (NASDAQ: KSPN) rose 19.1% to $0.8799.
  • Entrada Therapeutics, Inc. (NASDAQ: TRDA) jumped 18% to $19.16. Vertex (NASDAQ:VRTX) Pharmaceuticals and Entrada Therapeutics recently announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV) therapeutics for myotonic dystrophy type 1 (DM1).
  • Summit Therapeutics Inc. (NASDAQ: SMMT) gained 16.6% to $3.29.
  • 180 Life Sciences Corp. (NASDAQ: ATNF) rose 15.5% to $0.3101.
  • National Western Life Group, Inc. (NASDAQ: NWLI) gained 14.8% to $277.01.
  • 2U, Inc. (NASDAQ: TWOU) gained 14.1% to $7.95.
  • Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) jumped 13.1% to $11.38.
  • Ribbon Communications Inc. (NASDAQ: RBBN) surged 12.5% to $2.98.
  • Gaotu Techedu Inc. (NASDAQ: GOTU) gained 12% to $1.87. Gaotu Techedu, last month, reported a third-quarter FY22 sales decline of 45.6% year-on-year to RMB606.2 million ($85.21 million).
  • Mullen Automotive, Inc. (NASDAQ: MULN) jumped 11.5% to $0.2152 after the company announced it signed its first U.S. dealer partner.
  • Pinterest (NYSE:PINS), Inc. (NYSE: PINS) climbed 10.6% to $26.12. Piper Sandler upgraded Pinterest from Neutral to Overweight and raised the price target from $25 to $30.
  • ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) gained 10.1% to $7.84 after SVB Leerink initiated coverage on the stock with an Outperform rating and a $14 price target.
  • Angi Inc. (NASDAQ: ANGI) gained 9.7% to $2.3250 after Citigroup (NYSE:C) initiated coverage on the stock with a Buy rating and a $2.60 price target.
  • Pardes Biosciences, Inc. (NASDAQ: PRDS) rose 9.6% to $1.26. JMP Securities initiated coverage on Pardes Biosciences with a Market Outperform rating and announced a price target of $9.
  • MediaCo Holding Inc (NASDAQ: MDIA) rose 5.3% to $1.1485 after the company said it has divested the assets of Fairway Outdoor LLC to Lamar Advertising Company for $78.6 million.
  • Oracle Corporation (NYSE: NYSE:ORCL) gained 3% to $83.69 after the company reported better-than-expected results for its second quarter on Monday.
Losers
  • Quotient Limited (NASDAQ: QTNT) fell 46% to $0.37. Quotient announced intent to voluntary delist from the Nasdaq Global Market.
  • Argo Blockchain plc (NASDAQ: ARBK) shares fell 38.1% to $0.4246. Argo Blockchain recently announced a November operational update..
  • Avaya Holdings Corp. (NYSE: AVYA) dropped 38% to $0.7149. Avaya disclosed certain information related to ongoing constructive discussions with financial stakeholders.
  • Midatech Pharma plc (NASDAQ: MTP) fell 30% to $1.17. Midatech Pharma PLC proposed acquisition of Bioasis Technologies Inc.
  • China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) shares dipped 29% to $5.05 after gaining around 115% on Monday.
  • Getaround, Inc. (NYSE: GETR) fell 28.8% to $1.46 after dropping 32% on Monday. Getaround recently announced closing of business combination with InterPrivate II Acquisition Corp.
  • Edible Garden AG Incorporated (NASDAQ: EDBL) fell 24.4% to $0.3225 after jumping over 59% on Monday.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) dropped 24% to $0.1521. Clovis Oncology voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.
  • Aptevo Therapeutics Inc. (NASDAQ: APVO) fell 23.2% to $3.00. Aptevo Therapeutics shares surged 14% on Monday after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
  • Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) dropped 23% to $8.31.
  • Hyperfine, Inc. (NASDAQ: HYPR) shares fell 21.9% to $0.9601. Hyperfine, on December 6, committed to organizational restructuring designed to decrease costs, create streamlined organization to support business, and has terminated approximately 13% of its global workforce.
  • Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) dropped 20% to $0.80.
  • Harpoon Therapeutics, Inc. (NASDAQ: HARP) dipped 20% to $1.1250. Harpoon Therapeutics recently announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
  • HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) declined 19.8% to $0.8180.
  • Enzo Biochem, Inc. (NYSE: ENZ) fell 19.4% to $1.49 following Q1 results.
  • Ambrx Biopharma Inc. (NYSE: AMAM) shares fell 19.2% to $2.3099 after dipping 37% on Monday.
  • Adamas One Corp. (NASDAQ: JEWL) shares fell 17.3% to $3.9250.
  • Curis, Inc. (NASDAQ: CRIS) fell 17% to $0.5399. Curis shares announced additional clinical data from the TakeAim Leukemia study of emavusertib.
  • Bone Biologics Corporation (NASDAQ: BBLG) dropped 16.8% to $0.2446.
  • SeqLL Inc. (NASDAQ: SQL) fell 16.2% to $0.44.
  • The Lion Electric Company (NYSE: LEV) fell 14.5% to $2.2810. Lion Electric reported pricing of 19,685,040 unit offering at $2.54 per unit.
  • Aerovate Therapeutics, Inc. (NASDAQ: AVTE) fell 11.5% to $27.00. Aerovate Therapeutics, last month, posted a Q3 loss of $0.56 per share.
  • Nikola Corporation (NASDAQ: NKLA) fell 11.5% to $2.0699.
  • Silvergate Capital Corporation (NYSE: SI) dropped 11.5% to $18.80. JP Morgan maintained Silvergate Capital with an Overweight and lowered the price target from $50 to $30.
  • Engine Gaming and Media, Inc. (NASDAQ: GAME) fell 9.3% to $0.9584 after jumping 95% on Monday. The company last Thursday announced it has entered into an agreement to combine with GameSquare Esports.
  • JetBlue Airways Corporation (NASDAQ: JBLU) fell 8.6% to $7.03 as the company said it expects Q4 revenue per ASM at the low end of its guidance range.
Also check this out Ethereum Jumps Above This Major Level; Toncoin Emerges As Top Gainer.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.